Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Irinotecan,Oxaliplatin, and S1 in Patients With Advanced Pancreatic Cancer

NCT03726021 is registered in ClinicalTrials.gov with Qingdao Central Hospital as lead sponsor.

NCT NCT03726021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03726021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Irinotecan,Oxaliplatin, and S1 in Patients With Advanced Pancreatic Cancer
Lead sponsor
Qingdao Central Hospital
Phase
Phase 2
Overall status
Completed
Start date
January 26, 2018
Completion date
February 28, 2023
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overall survival